“The Role of NIV from Hospital to Home: Reducing COPD Readmissions”
Event Navigation
Philips* & Saxe Communications present…“The Role of NIV from Hospital to Home: Reducing COPD Readmissions”
Noninvasive ventilation (NIV) has been successfully used for decades to deliver positive pressure- ventilator support without the need of an artificial airway. Patients with acute and chronic respiratory failure, including those with chronic obstructive pulmonary disease (COPD), have benefitted from noninvasive ventilation. This webinar will focus on the clinical benefits of NIV for COPD patients as they progress through various stages of their care, transitioning from hospital to home. Differences in NIV terminology and technology will be addressed as well as common ventilation concerns in COVID-19 era.
Learning Objectives | At the end of this session, participants should be able to:
- Describe the clinical benefits of NIV.
- Describe difference in terminology between hospital NIV/Bilevel Positive Airway Pressure (NIV/BiPAP) and home NIV/BiPAP.
- Discuss the value of a NIV program including process, methodology and strategies in reducing COPD readmissions.
- Identify ventilation concerns in a COVID-19 era.
Speaker:
Maureen Lintner, BSRT, RRT | Pulmonary Disease Coordinator | Baptist Health | Miami, FL
Continuing Education for Nurses and Respiratory Therapists. This program has been approved for 1.0 contact hour. Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care. This education activity is approved for 1.0 contact hour. Provider approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032.
Educational support provided by Philips.*
*NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.
